Project: COMPETE2030-FEDER-00847900- ARTPD

Project name:	ARTPD - Anti-DDC RNA Interference Therapy in Parkinson´s Disease
Project code:	COMPETE2030-FEDER-00847900- ARTPD
Intervention Region:	Norte
Proposing institution/Lead promoter/Coordinating entity:	Faculdade de Medicina da Universidade do Porto
Date of approval:	2025-08-18
Start date:	2025-10-01
Completion date:	2028-09-29

Objectives, activities and expected/achieved results

The main outcomes of the proposal are the following: a) develop a first-in-class drug candidate that can modulate the excess iron and inflammatory events and regulate DA levels in the brain; b) feed the pipeline with new disease-modifying drug candidates for PD; c) patent the most promising candidates; d) knowledge transfer to pharmaceutical/biotech companies, namely those interested in the field of antiparkinsonians and therapeutic applications thereof; e) train undergraduate and graduate students and early stage researchers; f) disseminate innovative research in international, peer-review scientific journals and international conferences; g) increase the awareness for PD by disseminating our main results to the scientific community and to the society in general.

Recommend this page Top

Copyright 1996-2025 © Instituto de Ciências Biomédicas Abel Salazar I Terms and Conditions I Acessibility I Index A-Z
Page created on: 2025-12-17 at 23:35:26 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book